Trial Profile
Effects of long term ToBrAmycin InhalaTion SoluTion (TIS) once daiLy on Exacerbation rate in patients with non-cystic fibrosis bronchiectasis. A double blind, randomized, placebo and TIS twice daily (open label) controlled trial. The BATTLE study.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 22 Dec 2020
Price :
$35
*
At a glance
- Drugs Tobramycin (Primary)
- Indications Bronchiectasis; Fibrosis
- Focus Therapeutic Use
- Acronyms BATTLE
- 24 Aug 2016 New trial record